Telix Pharmaceuticals TLX
NASDAQ TLX
$9.27 +0.24 (+2.60%)
As of: Oct 28, 2026 · 11:43 AM EDT

Telix Pharmaceuticals (TLX) Market Capitalization (2024 - 2026)

Updated

Telix Pharmaceuticals' Market Capitalization came in at $3.91 billion for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Market Capitalization (2024 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Telix Pharmaceuticals' Market Capitalization was $2.54 billion, down 50.8% from the prior year.

  • Going back by year, Market Capitalization was $5.15 billion in the year ended Dec 31, 2024.
  • The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Market Capitalization since the quarter ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,154.85 Bn 1,123.44 Bn 19.71 Bn
2 Johnson & Johnson 655.17 Bn 575.03 Bn 17.30 Bn
3 AbbVie 508.69 Bn 481.81 Bn 12.70 Bn
4 Merck 349.10 Bn 303.48 Bn 12.21 Bn
5 Novartis Ag 303.63 Bn 276.87 Bn -
6 Astrazeneca 265.13 Bn 238.81 Bn 12.86 Bn
7 Amgen 245.03 Bn 200.43 Bn 7.24 Bn
8 Gilead Sciences 199.17 Bn 173.37 Bn 6.22 Bn
9 Pfizer 168.49 Bn 115.14 Bn 10.94 Bn
10 Telix Pharmaceuticals 3.13 Bn 2.09 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.91 Bn
Dec 31, 2025 2.54 Bn
Dec 31, 2024 5.15 Bn
API Access

Telix Pharmaceuticals Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=TLX&period=max&api_key=YOUR_API_KEY